254 related articles for article (PubMed ID: 37515699)
41. Anti-cancer potential of cannabis terpenes in a Taxol-resistant model of breast cancer.
Tomko AM; Whynot EG; O'Leary LF; Dupré DJ
Can J Physiol Pharmacol; 2022 Aug; 100(8):806-817. PubMed ID: 35704944
[TBL] [Abstract][Full Text] [Related]
42. Perillyl alcohol selectively induces G0/G1 arrest and apoptosis in Bcr/Abl-transformed myeloid cell lines.
Sahin MB; Perman SM; Jenkins G; Clark SS
Leukemia; 1999 Oct; 13(10):1581-91. PubMed ID: 10516760
[TBL] [Abstract][Full Text] [Related]
43. Recent developments in nanomedicine for melanoma treatment.
Tang JQ; Hou XY; Yang CS; Li YX; Xin Y; Guo WW; Wei ZP; Liu YQ; Jiang G
Int J Cancer; 2017 Aug; 141(4):646-653. PubMed ID: 28340496
[TBL] [Abstract][Full Text] [Related]
44. Synergistic inhibitory effect of berberine and d-limonene on human gastric carcinoma cell line MGC803.
Zhang XZ; Wang L; Liu DW; Tang GY; Zhang HY
J Med Food; 2014 Sep; 17(9):955-62. PubMed ID: 25045784
[TBL] [Abstract][Full Text] [Related]
45. Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol.
Stark MJ; Burke YD; McKinzie JH; Ayoubi AS; Crowell PL
Cancer Lett; 1995 Sep; 96(1):15-21. PubMed ID: 7553603
[TBL] [Abstract][Full Text] [Related]
46. Better targeting melanoma: options beyond surgery and conventional chemotherapy.
Kyrgidis A; Valasidis A; Bourlidou E; Andreadis C
Recent Pat Endocr Metab Immune Drug Discov; 2011 May; 5(2):147-59. PubMed ID: 22074588
[TBL] [Abstract][Full Text] [Related]
47. Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells.
Pisano M; Pagnan G; Loi M; Mura ME; Tilocca MG; Palmieri G; Fabbri D; Dettori MA; Delogu G; Ponzoni M; Rozzo C
Mol Cancer; 2007 Jan; 6():8. PubMed ID: 17233906
[TBL] [Abstract][Full Text] [Related]
48. Neuroprotective Effects of Limonene (+) against Aβ42-Induced Neurotoxicity in a Drosophila Model of Alzheimer's Disease.
Shin M; Liu QF; Choi B; Shin C; Lee B; Yuan C; Song YJ; Yun HS; Lee IS; Koo BS; Cho KS
Biol Pharm Bull; 2020 Mar; 43(3):409-417. PubMed ID: 31875578
[TBL] [Abstract][Full Text] [Related]
49. Anti-Cancer Effects of
Park J; Kwon M; Lee J; Park S; Seo J; Roh S
Molecules; 2020 Aug; 25(17):. PubMed ID: 32859054
[TBL] [Abstract][Full Text] [Related]
50. Systemic treatment of malignant melanoma.
Mota A; Deisseroth A
Clin Plast Surg; 2000 Jul; 27(3):463-74, x. PubMed ID: 10941566
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant therapy for malignant melanoma.
Stoutenburg JP; Schrope B; Kaufman HL
Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
[TBL] [Abstract][Full Text] [Related]
52. MIA--a new target protein for malignant melanoma therapy.
Schmidt J; Riechers A; Bosserhoff AK
Histol Histopathol; 2013 Apr; 28(4):421-6. PubMed ID: 23192727
[TBL] [Abstract][Full Text] [Related]
53. In vitro selective cytotoxicity of the dietary chalcone cardamonin (CD) on melanoma compared to healthy cells is mediated by apoptosis.
Berning L; Scharf L; Aplak E; Stucki D; von Montfort C; Reichert AS; Stahl W; Brenneisen P
PLoS One; 2019; 14(9):e0222267. PubMed ID: 31553748
[TBL] [Abstract][Full Text] [Related]
54. [Advances in clinical treatment of malignant melanoma: B-RAF kinase inhibition].
Heneberg P
Klin Onkol; 2011; 24(4):256-64. PubMed ID: 21905615
[TBL] [Abstract][Full Text] [Related]
55. Antiproliferative activity of vanadium compounds: effects on the major malignant melanoma molecular pathways.
Pisano M; Arru C; Serra M; Galleri G; Sanna D; Garribba E; Palmieri G; Rozzo C
Metallomics; 2019 Oct; 11(10):1687-1699. PubMed ID: 31490510
[TBL] [Abstract][Full Text] [Related]
56. Trametinib for the treatment of melanoma.
Alluri N; Jimeno A
Drugs Today (Barc); 2013 Aug; 49(8):491-8. PubMed ID: 23977666
[TBL] [Abstract][Full Text] [Related]
57. Anticancer Activity of Two Novel Hydroxylated Biphenyl Compounds toward Malignant Melanoma Cells.
Pisano M; Dettori MA; Fabbri D; Delogu G; Palmieri G; Rozzo C
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073232
[TBL] [Abstract][Full Text] [Related]
58. Effect of naturally occurring monoterpenes carvone, limonene and perillic acid in the inhibition of experimental lung metastasis induced by B16F-10 melanoma cells.
Raphael TJ; Kuttan G
J Exp Clin Cancer Res; 2003 Sep; 22(3):419-24. PubMed ID: 14582701
[TBL] [Abstract][Full Text] [Related]
59. Combination of ω-3 fatty acids and cisplatin as a potential alternative strategy for personalized therapy of metastatic melanoma: an in-vitro study.
Ottes Vasconcelos R; Serini S; de Souza Votto AP; Santos Trindade G; Fanali C; Sgambato A; Calviello G
Melanoma Res; 2019 Jun; 29(3):270-280. PubMed ID: 30550405
[TBL] [Abstract][Full Text] [Related]
60. Limonene: Aroma of innovation in health and disease.
Vieira AJ; Beserra FP; Souza MC; Totti BM; Rozza AL
Chem Biol Interact; 2018 Mar; 283():97-106. PubMed ID: 29427589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
